PharmaLectures.com

Courses › Regulatory affairs by region › Latin America: Brazil ANVISA, registration, foreign-site GMP and surviving the inspection queue

Latin America: Brazil ANVISA, registration, foreign-site GMP and surviving the inspection queue

Your team gets Brazil dossiers, site files and inspection answers right the first time.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

A deficiency letter from ANVISA, the Brazilian National Health Surveillance Agency, reaches your importer, and the foreign site file contradicts the dossier. Regulatory affairs rewrites while quality assurance hunts for records, and the launch date passes. The inspection queue does not wait.

What changes after this course

Your team files dossiers that clear first screening, keeps the site file consistent with them, and answers inspection findings in one pass. You hold a certificate per learner and a per-person training record for your compliance files.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs manager opens a new file for the Brazilian National Health Surveillance Agency (ANVISA) and knows which resolution applies to the product category, without a call to legal. The product is classified correctly on day one, the local partner signs the administrative forms, and the technical data sits where the reviewer looks first. The Portuguese dossier stops being a translation of the European one.

Quality assurance lines up the foreign site against Resolution of the Collegiate Board (RDC) 658/2022 and writes a Site Master File that answers the inspector in advance. Floor operators rehearse the questions auditors ask. Batch records are pulled and translated before the visit, and the water system validation records are in the folder, not in someone's memory.

Business development tracks the certification request and sets launch dates from what ANVISA has actually said about the inspection queue. When a finding arrives, the team traces it to its root cause and answers with a corrective and preventive action plan the inspector can close. Renewals go in before certificates expire.

After approval, the compliance officer decides on the spot whether a change is a major variation or a notification, and in what order a minor change goes in while a renewal is pending. Documentation errors that trigger rejection get caught inside the company, and the official gazette is watched for the next rule change.

Who needs this training

  • Regulatory Affairs Manager

    A European dossier is being adapted for Brazil and a deficiency letter is the fear. This gives the forms, formats and product classification that keep the file from coming back at first screening.

  • Quality Assurance Director

    An ANVISA inspection is announced for a foreign site and the Site Master File, batch records and operators are not ready. This gives the RDC 658/2022 expectations to prepare against.

  • Business Development Lead for Latin America

    A launch date slips because the manufacturing site sits in the inspection queue. This shows what moves a site up or down the queue and how to time certificate renewals.

  • Compliance Officer for Post-Approval Changes

    A supplier change or minor variation lands while a renewal is pending. This settles whether it is a notification or a major variation, and what to file first.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Latin America

Courses are in English. Other languages on request.

After this course your people can

  1. Classify a pharmaceutical or biological product for ANVISA registration and explain why it is or is not a new molecule.
  2. Assemble a submission dossier with the required administrative forms so it passes initial Brazilian screening.
  3. Map a foreign site's procedures against RDC 658/2022 and list the gaps before an inspector finds them.
  4. Draft a Site Master File that supports your ANVISA certification request.
  5. Coach foreign site operators for the questions ANVISA inspectors tend to ask.
  6. Write a corrective and preventive action plan that lets the inspector close a finding.
  7. Decide whether a post-approval change needs a major variation or a notification, and file renewals before expiry.

What the company gets

  • Your Brazilian dossiers stop coming back for avoidable formatting and signature errors, so regulatory affairs time goes to new filings.
  • Your foreign sites reach an ANVISA inspection with a Site Master File, batch records and prepared operators already in order.
  • Your launch plan rests on a clear view of the inspection queue and of your Brazilian importer's role in it.
  • Your registrations and certificates are renewed before they expire, so Latin American sales are not interrupted by paperwork.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map ANVISA's framework and authority to know who reviews your file first

    • How to find the Brazilian resolution that governs your product category before you draft a page.
    • The ANVISA structure that decides which department opens your application first.
    • Why a file that satisfies the European Medicines Agency still draws deficiency queries in Brazil.
  2. 2Classify your product correctly for ANVISA registration on day one

    • How to pick the category that puts your product on the faster review track.
    • What makes ANVISA treat your drug as a new molecule, so you plan the timeline before filing.
    • When your biological product counts as a new biological and when it counts as a biological product.
  3. 3Assemble the ANVISA submission documents that pass initial screening

    • The administrative forms your Brazilian partner must sign before anything goes to ANVISA.
    • How to lay out technical data so the reviewer finds the answer on the first page.
    • Why a direct Portuguese translation of your European dossier leaves gaps against ANVISA rules.
  4. 4Align your foreign site with RDC 658/2022 before the inspector asks

    • How to map your procedures to RDC 658/2022 and see the gaps before an inspector does.
    • The water system validation records ANVISA expects from a foreign manufacturer.
    • What to show the inspector when your site makes medicines alongside other product categories.
  5. 5Build a Site Master File that supports your ANVISA certification

    • How to structure the Site Master File so it answers ANVISA's questions before they are asked.
    • The floor plan details that stall certification, and how to fix them before you submit.
    • Why a United States Food and Drug Administration filing cannot replace the Site Master File ANVISA expects.
  6. 6Prepare your foreign site and its people for the ANVISA inspection

    • How to prepare your operators for the questions ANVISA inspectors tend to ask.
    • The batch records to pull and translate before the Brazilian auditors arrive.
    • What to do when an inspector asks for a document outside the agreed inspection scope.
  7. 7Move up the ANVISA foreign site inspection queue

    • How ANVISA's risk-based prioritisation criteria set your place in the foreign site inspection queue.
    • The application updates to check before you file, so your place in the waiting list is not put at risk.
    • Why your Brazilian importer and your site should coordinate on inspection and certification requests.
  8. 8Draft corrective responses that close ANVISA inspection findings

    • How to read the inspection report and find the root cause ANVISA wants fixed.
    • How to read the deadline ANVISA sets for the corrective and preventive action plan and plan backward from it.
    • What to write in a deficiency response so the inspector can close the finding on first reading.
  9. 9Submit post-approval changes without triggering a new review

    • How to tell a post-registration change needing prior approval from a simple notification before you file.
    • The documents ANVISA expects when you change your active pharmaceutical ingredient supplier.
    • How to check whether a minor change can be filed while a renewal request is still pending.
  10. 10Renew your ANVISA registrations and certificates before they lapse

    • When to file renewals so your product stays legally on the Brazilian market.
    • The commercialisation evidence ANVISA wants to see that your product is still active in Brazil.
    • How to plan renewal timing so your site certificate is not left exposed to inspection delays.
  11. 11Spot the documentation errors that get ANVISA to reject a file

    • The documentation errors that get a dossier returned at initial screening.
    • How to answer an ANVISA query completely and avoid inviting a second round of questions.
    • Why one missing signature on a technical report can turn into a deficiency requirement.
  12. 12Adapt your quality system to upcoming ANVISA regulatory shifts

    • How to watch the Brazilian official gazette for rule changes before they reach your site.
    • The internal audit checks that keep your site ready for a scheduled ANVISA visit.
    • What to adjust in your quality system when ANVISA adopts a new international harmonised standard.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team